CorMedix Inc. — Director's Dealing 2014

Jan 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2014-01-10

Reporting Person: Pfaffle Antony (Director, Interim Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-10	Stock Option (right to buy)	$2.02	A	100000	Acquired	2024-01-09	Common Stock, $0.001 par value per share (100000)	Direct
2014-01-10	Stock Option (right to buy)	$2.02	A	30000	Acquired	2024-01-09	Common Stock, $0.001 par value per share (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.001 par value per share	16725	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.9	2023-03-22	Common Stock, $0.001 par value per share (210000)	210000	Direct
Stock Option (right to buy)	$0.68	2022-12-05	Common Stock, $0.001 par value per share (250000)	250000	Direct
Stock Option (right to buy)	$0.29	2022-01-06	Common Stock, $0.001 par value per share (30000)	30000	Direct
Stock Option (right to buy)	$2.1	2021-01-14	Common Stock, $0.001 par value per share (30000)	30000	Direct
Stock Option (right to buy)	$3.125	2020-03-30	Common Stock, $0.001 par value per share (20000)	20000	Direct

Footnotes

F1: The options vested 100% on January 10, 2014.

F2: The options vest in full on the first anniversary of the date of grant.

F3: These options vest based on performance milestones running through December 31, 2014.

F4: These options vest as follows: (a) fifty percent (50%) on the date of issuance of the CE Mark certification, which occurred on July 5, 2013, and (b) fifty percent (50%) on December 31, 2013.

F5: These options vested on January 14, 2012.

F6: These options vest as follows: 1/3 on March 30, 2010, an additional 1/3 on March 30, 2011, and the remaining 1/3 on March 30, 2012.